However, a systematic review indicated that the effects of PIK3CA mutations on survival outcomes are unclear, and the majority of the included studies support a the potentially negative effect, primarily among those with squamous cell carcinoma [15]. This evidence concerns the gene PIK3CA and squamous cell carcinoma.